T o the modern mind, the term 'sepsis' conjures up images of microbes. It is easy to forget that the word predates any understanding of the microbial origins of infectious disease. Derived from the Greek 'sepsios' (rotten), sepsis denotes decay: a phenomenon that humans once regarded as a mysterious though inevitable natural process. A living organism does not accept decay passively. Virtually all multicellular life forms are capable of resisting infection through the generation of a vigorous immune response. In mammals, the response is so stereotypic that it has come to define sepsis itself: it is often called the 'septic syndrome'. Our current understanding of the innate immune system is deeply rooted in the study of sepsis. T h e chain of events linking infection to tissue injury and cardiovascular collapse is not obvious, and affirmation of the concept required three major discoveries. First, the septic syndrome was found to be caused by toxic products of microbes. Secondly, these toxic substances were found to be toxic because of their propensity to activate cells of the innate immune system, prompting cytokine production. Thirdly, the activating events initiated by microbial toxins were traced to members of an ancient family of defensive molecules, versions of which operate in virtually all multicellular life forms. In mammals, proteins of this family are now known as Toll-like receptors. They represent a point of direct contact, and first contact, between a pathogen and the host immune system.
Sepsis and the toxicity of microbial infections
T h e infectious character of many diseases has been known since antiquity, as has the basic character of these diseases. Though lacking in any knowledge of microbial pathogenesis, the earliest physicians were undoubtedly aware of the similarity between the natural processes of decay witnessed in inanimate matter, and in living tissue. They were also aware of the systemic toxicity that attends severe infection in human beings.
As has been eloquently reviewed elsewhere [l], a systematic approach to the study of what was already called 'sepsis' began several hundred years ago. Abrecht von Haller and Franqois Magendie each analysed sepsis using tools that seem quite crude today. Nonetheless, their work fostered the understanding that putrid organic material could not only transfer infection, but was acutely toxic to animals that were injected with it. Ernest von Bergmann coined the term 'sepsin' to describe a toxic principle associated with pus derived from the wounds of infected patients. T h e Danish pathologist Peter Panem undertook the isolation of a similar factor. He arrived at a preparation of an alcohol-insoluble, heat-stable material, 12 mg of which was sufficient to kill a large dog. It is clear to us that Panem had isolated bacterial endotoxin, or lipopolysaccharide (LPS), though neither name had yet been applied to the substance. T h e term 'endotoxin' was coined by Richard Pfeiffer, who worked in the early post-microbial era. T h e name was meant to denote the 'fixed' character of this toxin, which remained in tight association with the Vibrio cholerae organisms with which Pfeiffer was working. Endotoxin was intensely pyrogenic, and, as was later learned, could provoke shock, coagulopathy, and tissue injury comparable to that witnessed in an authentic infection.
T h e LPS nature of endotoxin isolated from various species of Gram-negative bacteria was deduced in the middle of the 20th century, and ultimately the chemical structure of a number of LPS molecules was solved. While LPS is certainly not the only toxic product of micro-organisms (Gram-positive organisms do not produce it), its high stability, toxicity and abundance propelled it to the forefront of investigations into the pathogenesis of sepsis. For nearly a century, it has stood as a model inducer of the host response to infection. T o understand how endotoxin works is, in large part, to understand the pathogenesis of sepsis.
The nature of endotoxicity
At one time, it was assumed that LPS might exert its effects directly ; for example, through perturbation of the plasma membrane lipid structure in mammalian cells, or through an ionophoric effect. T h e hydrophobic character of LPS was consistent with the idea that the substance might intercalate into the plasma membrane of mammalian cells, and thereby disrupt normal function. Consistent with this viewpoint is the fact that lipid A moiety of LPS was found to be toxic, whereas the polysaccharide moiety was bereft of toxicity.
This early and somewhat simplistic view of LPS pathogenesis did not take account of the enormous differences in sensitivity observed between species, and particularly, between vertebrate classes. For example, mammals are quite sensitive to the toxic effects of LPS, whereas birds, reptiles, amphibians and fish are not. Moreover, some mammalian species are approximately 1000-fold more sensitive to LPS than others. Furthermore, developmental differences in LPS sensitivity have been reported, particularly in birds [2] , wherein an early and transient phase of L P S hypersensitivity occurs in the embryo.
Four very important observations foreshadowed the identification of the LPS signalling 0 200 I Biochemical Society pathway. T h e first of these was made in 1965, with the fortuitous observation that mice of the C3H/ HeJ strain were impervious to the lethal effect of LPS, seemingly as the result of a spontaneous genetic change that became fixed in this C3H substrain sometime during the early 1960s [3] . Animals of the related C3H/HeN and C3H/OuJ substrains showed normal sensitivity to LPS [4].
Detailed genetic studies revealed that C3H/HeJ mice had sustained a single co-dominant mutation that prevented LPS responses. This mutation was loosely mapped to chromosome 4 in 1978 by 6] . Of equal importance, a second mutation affecting LPS sensitivity was identified in a Mus musculus strain unrelated to C3H/HeJ [7] . This mutation, which occurred in the C57BL/lOScCr strain of mice, was unequivocally shown to affect the same locus as the C3H/HeJ mutation. This locus was termed Lps, and the mutant allele that prevented LPS responses was termed Lpsd.
In the homozygous form, both mutations were found to compromise survival following infection with Gram-negative bacteria [7-91. This suggested, as many had expected, that LPS recognition by the host contributed to the elimination of an infectious pathogen, presumably by activating cells of the innate immune system.
Perhaps the most important lesson to be drawn from these relatively early genetic studies concerns the solitary nature of the LPS signal transduction pathway. Although many proteins might prove to be required for an effective response to LPS, it is a fact that there is absolute dependence upon a single protein. This protein was assumed from the earliest stage to represent at least one component of the plasma membrane receptor for LPS. On this basis, several investigators attempted to raise antibodies that would recognize a unique determinant in C3H/HeJ mice, or later, a unique determinant in C57BL/lOScCr mice. This approach to the identification of the LPS receptor was ultimately unsuccessful. However, the fact that a single mutation blocked LPS signalling eliminated the possibility that LPS evoked its toxic effects by promiscuous interactions with plasma membrane lipids. Rather, a single protein target must exist. It was not plausible that several independently functioning pathways could transduce the LPS signal.
T h e second key discovery bearing upon the nature of endotoxicity was made in 1980, with the demonstration that, whatever its effects on other somatic cells, the lethal effect of L P S was entirely conferred by cells of hematopoietic origin [lo] . Therefore, C3H/HeJ mice became sensitive to the lethal effect of LPS if they were irradiated and then ' reconstituted ' using hematopoietic cells derived from the C3H/HeN substrain. In the reciprocal experiment, C3H/HeN mice were rendered resistant to LPS by irradiation and reconstitution using hematopoietic progenitors from C3H/HeJ mice. Ultimately, macrophages were shown to be of principal importance in transduction of the lethal signal.
T h e third major discovery that led to identification of the LPS signal transducer was the recognition that specific cytokines mediate endotoxicity, and concomitantly, the understanding that LPS activates a collection of cytokine genes, leading to exaggerated expression of the corresponding proteins. T h e first and most important of these endogenous mediators to be discovered was tumour necrosis factor (TNF). In 1985, it was shown that passive immunization against T N F could substantially reduce the lethal effect of subsequent challenge with LPS, suggesting that T N F was at least largely responsible for the lethal effect of LPS [ l l ] . This observation was substantiated by gene knockout work completed 8 years later [12, 13] , which also revealed the key importance of the type I T N F receptor, and confirmed the observation of Have11 [14] , who had shown previously that T N F blockade would very much impair the innate immune response. Therefore, mice were incapable of responding effectively to infection by Listeria, or to Mycobacterium bovis [15] if the normal T N F signalling axis was disrupted. T N F biosynthesis, therefore, became a useful and biologically relevant endpoint to measure in studies of the endotoxin response.
While these three steps clarified the basic sequence of events that transpired when endotoxin was administered to an animal, they did not, at first, shed light upon the basic transduction mechanism utilized by LPS. T h e receptor remained elusive. T h e fourth major advance, however, was to occur in 1990, with the discovery of the first biologically relevant plasma membrane LPSbinding protein. Using a transfection-based approach [16], Wright et al. determined that the glycosylphosphoinositol-linked membrane protein CD14 was required for LPS signal transduction in a lymphocyte-derived cell line. CD14 was later found to exist in a soluble form as well, and in either form it can bind endotoxin with relatively high affinity. A hepatically-derived acute phase reactant, called lipopolysaccharide-binding protein that was first isolated in the mid-1980s [17] , was shown to promote the transfer of LPS from the plasma to CD14 on the surface of mononuclear cells [ 181. Lipopolysaccharidebinding protein and CD14 emerged as important concentrating mechanisms that would enhance the toxicity of LPS. In mice lacking CD14, the lethal dose of LPS was shown to be far higher than in control animals. But an important mystery persisted; there was no clear understanding of the means by which the LPS signal could cross the plasma membrane and lead to macrophage activation. CD14, an abundant surface protein of mononuclear cells, has no cytoplasmic domain and, therefore, cannot transduce a signal by itself.
In many laboratories, attention returned to the C3H/HeJ mouse and its normal counterparts, C3H/HeN and C3H/OuJ. It was appealing to think that the transmembrane component of the LPS receptor might be encoded by the gene that was mutated in C3H/HeJ and in C57BL/lOScCr mice. Equally appealing was the thought that a proximal cytoplasmic transducer might be encoded by the gene. It was already known that numerous protein kinase pathways, including a tyrosine kinase pathway, were activated by LPS. Accordingly, many earnest attempts were made to clone the Lps gene.
T h e earliest attempts took the form of efforts to identify a protein difference between C3H/HeJ and C3H/HeN mice. Subsequently, expression cDNA cloning approaches were attempted. One such attempt, which proceeded to completion, pinpointed the wrong gene : the GTP-binding protein Ran/TC4 [19] that probably has no connection to LPS signalling [20] . Other expressionbased efforts, though pursued energetically, were essentially fruitless and were never published.
Cross immunization of C3H/HeJ and C3H/ HeN mice, each with cells derived from the opposite strain, did not yield antibodies specific for the product of Lps. However, though it seems somewhat odd in retrospect, antibodies specific for C3H/HeJ macrophages were produced by immunizing rabbits, and purportedly led to the identification of the C57BL/IOScCr mouse [21, 22] . But the antibody, if truly specific, did not lead to any further results. In the early 1990s, the growing density of chromosomal markers in the mouse made a positional attempt on the Lps locus feasible. Several groups began to approach the gene through meiotic mapping studies, and through the construction of contigs that spanned the critical region containing the gene.
In 1998, Poltorak and co-workers announced the identification of the mutation that was responsible for LPS resistance in C3H/HeJ mice [23, 24] . A single nucleotide substitution, corresponding to the replacement of a conserved proline residue in the cytoplasmic domain of the Toll-like receptor 4 (TLR4), was responsible for the total ablation of endotoxin sensitivity in the C3H/HeJ mouse. In C57BL/lOScCr mice, the T L R 4 locus was found to be deleted entirely. Ultimately, a 74 kb deletion, affecting the T L R 4 gene but no other genes in the region, was defined by PCRbased mapping and further genomic cloning work T h e fact that both of the two LPS-resistant strains had sustained T L R 4 mutations while congenic controls were normal at the T L R 4 locus proved the case that T L R 4 was absolutely required for LPS signal transduction. Although transfection-based studies concurrently implicated a different protein as the LPS transducer [26, 27] , the credibility of this conclusion was thoroughly undermined by the fact that mutations at the T L R 4 locus completely abrogated LPS signalling. Therefore, as Poltorak et al. pointed out [23] , there was no 'accessory' signal transduction pathway to support LPS signalling as it occurs in oivo, and the notion that T L R 2 might serve as an LPS transducer was untenable.
In this manner, it became apparent that T L R 4 functions as the transducing subunit of the LPS sensor in mammalian cells. Earlier work, already outlined above, had demonstrated that this sensing function is important in the protection of the host. Still more interesting, however, was the fact that T L R 4 was only one member of an ancient family of proteins known to subserve defensive functions not only in mice, but in Drosophila, and even in plants. These receptors, and their defensive function in Drosophila, had been the subject of an inquiry entirely removed from the story as it has been told thus far. ~5 1 .
The dual nature of Toll in Drosophila
In the mid-1980s a collection of mutations required for dorsoventral polarization of the Drosophila embryo were identified and studied using genetic complementation techniques (reviewed by Belvin and Anderson [28] ). T h e so-called 'dorsal group' included genes encoding a series of extracellular proteases that would cleave a pro-peptide, yielding Spatzle, the putative ligand for a plasma membrane receptor designated Toll. Through 0 2001 Biochemical Society interaction with the cytoplasmic proteins pelle and tube, Toll would signal the activation of dorsal, a member of the re1 family of oncogenes [which also includes nuclear factor KB (NF-KB)]. After dissociating from cactus, another member of the dorsal group (dorsal itself) would translocate to the nucleus and stimulate the expression of genes required for polarization of the embryo [29] .
Proceeding from the observation that certain anti-microbial peptide genes (including the gene for drosomycin, an anti-fungal peptide) had NF-KB motifs in their promoters, Hoffmann and coworkers [30] determined that another member of the re1 family, known as dif, was required for drosomycin expression. Moreover, all of the proteins that were essential for dorsoventral polarization in the embryo, starting with Spatzle, were required for the response of flies to fungal infection. Hence, flies with viable mutations of Toll were unable to mount an adequate defence when inoculated with spores from the fungus Aspergillus fumigatus. T h e proteolytic cascade upstream from Spatzle, components of which resemble proteins in the complement cascade and clotting cascade of mammals, was, however, irrelevant to the antimicrobial response.
T h e dual function of Toll, during development and during the immune response, now appears to be a somewhat isolated example, in that the defensive function is probably the primordial one. Hence, in plants, proteins with structural similarity to Toll and the mammalian T L R s are involved in the response to infection [31] . T h e developmental function of Toll in Drosophila is not duplicated in other species studied to date.
Structural features of the TLR family
All of the T L R s (and all of the so-called 'Tolls' of Drosophila, in which species eight other transmembrane receptors homologous to Toll are known to exist) exhibit leucine-rich repeats in the ectodomain, though these are arranged somewhat haphazardly, and are not known to be the basis of a characteristic superstructure. A special ' membrane proximal ', leucine-rich repeat is present in most members of the family, and contains a number of cysteine residues that may participate in the formation of a constant, ordered structure. Mutation of at least some of these cysteines is known to produce a hypermorphic effect in Drosophila [32] .
All of the T L R s are believed to be single plasma membrane-spanning proteins, and all are marked by a single, large conserved domain known as the Toll/interleukin (I L)-1 receptor motif. This motif is also represented in the mammalian IL-1 receptor chains, the homologous IL-18 receptor chains, the orphan receptors SIGIRR and ST2, and the cytoplasmic transducer molecule MyD88. It is widely believed that the Toll/IL-1 receptor motif is a protein interaction domain that permits association between MyD88 and all of the receptors, leading to many (perhaps most) of the signalling events that transpire. However, there are many differences both in the quality and intensity of the signals that are generated by different members of the family. Therefore, it is suspected that other molecules also engage these receptors. Certain lines of evidence also suggest the formation of heterodimers between different members of the receptor family. For example, it has been shown that T L R 2 can associate with either T L R l or TLR6. These latter family members are very similar to one another, having diverged only recently in the course of evolution. These distinct heterodimers appear to transduce signals initiated by different ligands (see below). Collectively, the T L R s are thought to represent the primary sensors of the innate immune system. They represent the principal avenue by which leukocytes are able to perceive host infection.
What ligands do TLRs sense?
Subsequent to the determination that T L R 4 is essential for LPS signal transduction, gene knockout studies revealed that T L R 2 is required for the transduction of signals initiated b y bacterial lipopeptides, or peptidoglycan, common constituents of both Gram-negative and Gram-positive bacteria [33] . Bacterial DNA, which unlike mammalian DNA is unmethylated at CpG dinucleotide residues, is also sensed by a T L R . Mice lacking T L R 9 cannot recognize DNA containing unmethylated CpG residues, whereas normal animals can [34] . It is likely that this interaction accounts for the adjuvant effect of bacterial DNA, used to advantage in experimental immunization. Still more recently, T L R 5 has been implicated as the transducer of signals initiated by bacterial flagellin [35] , also a component of both gramnegative and gram-positive organisms.
At present, there are ten mammalian TLRs, and one of the principal challenges to the emerging T L R field concerns the determination of specificity; which T L R detects which pathogen? Transfection-based methods have mainly been used to assign specificity. Regrettably, these methods have proven to be unreliable, partly because many preparations of microbial inducers are not chemically pure, and partly because a rather non-specific assay system is used, involving massive overexpression of T L R s in 293 cells and the detection of NF-KB activation: surely among the most common of stress responses within most cells. Six of the T L R s remain 'orphans' to the present day, although it has been shown that T L R l and T L R 6 (and by implication, the very similar TLRlO) act in conjunction with T L R 2 to detect cell wall products [36] . T h e elucidation of specificity is likely to depend upon the analysis of knockout mutations disrupting each of these receptors.
In the literature published to date, a number of false attributions of specificity are already apparent. For example, it is the author's opinion that T L R 4 does not transduce the RSV (respiratory syncitial virus) F protein signal, nor is it likely that it can transduce the signals from heatshock proteins HSP60 or HSP70. Indeed, the informational content of any protein is necessarily limited, and at present, the number of putative ligands for both T L R 2 and T L R 4 is probably far greater than the number of actual ligands.
Mechanism of sensing
Genetic complementation studies clearly indicate that Spatzle has direct contact with the Drosophila Toll protein. In fact, a direct demonstration of such contact has never been made. But there are a few alternative interpretations to be made, and genetic data bearing upon an interaction are often more robust than physical data. A similar situation applies in the case of LPS and TLR4. Although it was expected that a protein intermediate might subserve the activation of T L R 4 by LPS, no Spatzle equivalent has ever been found. It is unlikely that such a protein exists in the mammalian genome. On the other hand, genetic complementation studies using LPS partial structures give strong evidence for a direct interaction between the microbial product and the mammalian receptor. While mouse macrophages are able to respond to tetra-acyl forms of lipid A, human macrophages cannot. This interspecies difference is entirely explained by structural differences between mouse and human TLR4. Therefore, LPS-unresponsive macrophages from C3H/HeJ mice respond to tetra-acyl lipid A if transfected to express the normal mouse T L R 4 isoform, but failed to respond if transfected to express the normal human T L R 4 isoform [37] . A similar This very observation raises yet another point. T h e difference between human and mouse T L R 4 amounts to a complex mutational difference. Might more restricted mutational differences also affect ligand preference, or the intensity of response to a given ligand? And might mutations of T L R 4 engender heightened susceptibility to gram-negative infection in humans as they clearly do in mice? This issue is developed more fully below.
Afferent defects of TLR function and the heritability of susceptibility to infection
T h e strong heritability of human susceptibility to infectious disease [40] occasions speculation concerning the loci and mutations that are involved. Specifically, one might ask whether susceptibility resides in loci governing innate or adaptive immunity, and in either case, whether mutations influence the afferent (sensing) component of the immune response, or effector function. Examples of effector defects of innate immunity (e.g. chronic granulomatous disease) and primary immunodeficiency disorders that ablate lymphocytes are well known, as are sensing defects of adaptive immunity (e.g. agammaglobulinemia and T-cell receptor defects). However, to date, no clear examples of sensing defects have been described in the innate immune system in human populations.
There are probably two explanations for this. First, the redundancy of receptor function in the innate immune system makes such defects difficult to identify, although they may well influence survival. Secondly, based on population studies performed to date [41] , all of the T L R loci are likely to be subject to weak purifying selection, and mutations that exist in the population are rather rare codominant defects, with no balancing beneficial effects, and with a short evolutionary lifespan.
In a recent analysis of T L R mutations in meningococcal septicemia (Smirnova, Mann, Dols, Derkx, Hibberd, Levin and Bentler, unpublished data), it was observed that patients with meningococcal sepsis have an excess of rare coding mutations at the T L R 4 locus, and a marked scarcity of a rather common polymorphism at the T L R 2 locus. It was concluded that approx. 6",, of meningococcal disease in the European population can be explained by mutations altering T L R 4 structure, while approx. 1Oo0 of the European population is protected against meningococcal disease based on carriage of a variant T L R 2 allele. Insofar as there are ten T L R loci, and several associated proteins required for T L R signal transduction, a rather large fraction of the heritability of infectious diseases may indeed reflect differences in sensing imparted by mutations at these loci.
In the future, given continued improvements in sequencing technology, the T L R loci could be kept under surveillance in order to assess disease susceptibility. I t is also possible that certain T L R mutations may be related to non-infectious diseases. For example, the classical P712H mutation at the T L R 4 locus in mice may have a strong modulating effect upon the development of autoimmune glomerulonephritis caused by the Fas mutation in mice [42] .
Summary: whither innate immunity?
T h e T L R s present themselves as appealing targets for pharmacological intervention in specific diseases in which inflammatory consequences exceed the threat of infection itself, and also stand as targets for genetic studies aimed at understanding the heritability of susceptibility to infection. But there is still more to the story than that. T h e discovery of the afferent mechanism of innate immunity was a classic effort that has many lessons to offer in its own right.
T h e identification of the T L R s as primary innate immune sensors was achieved b y the use of powerful genetic methods, and demonstrated (as witnessed in so many other settings) the use of a single gene mutation as a tool for enlightening function in a very complex biological process. T h e T L R s are not the sole sensors of infection. For example, the formylmethionyl-leucylphenylalamine (fMLP) receptor probably triggers a response to bacteria that is functionally related to the T L R response, if distinct in terms of signalling mechanism. There may be many other receptors awaiting discovery, and surely, there are details of signalling yet to be unravelled. But the best route to finding such proteins is now clear: mutations must lead the way. For this reason, it may be predicted with confidence that forward genetic methods (for example, mutagenesis in mice) will ultimately result in the discovery of all innate immune proteins. By identifying all mutations that destroy innate immunity, we will ultimately come to grasp all of the proteins that are fundamentally involved in generating the innate immune response, communicating with the adaptive immune system, and thereby defending the host.
